Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
9.52
-0.16 (-1.65%)
At close: Oct 17, 2025, 4:00 PM EDT
9.33
-0.19 (-2.00%)
After-hours: Oct 17, 2025, 5:54 PM EDT
Arvinas Market Cap
Arvinas has a market cap or net worth of $698.94 million as of October 17, 2025. Its market cap has decreased by -59.08% in one year.
Market Cap
698.94M
Enterprise Value
-152.36M
1-Year Change
-59.08%
Ranking
Category
Stock Price
$9.52
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $698.94M, an increase of 35.41%. That is a compound annual growth rate of 4.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 710.68M | -46.05% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | 4.09B | 159.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.28B |
| Johnson & Johnson | 459.63B |
| AbbVie | 404.77B |
| UnitedHealth Group | 325.98B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 231.95B |